ACE 031（1mg*10vials）

ACE 031 is a soluble fusion protein that acts as a potent inhibitor of the myostatin signaling pathway, designed to research the mechanisms of significant muscle growth and strength enhancement. It is constructed by fusing a portion of the human activin receptor type IIB (ActRIIB) to the Fc portion of a standard antibody. In the body, myostatin and other proteins like GDF-11 act as negative regulators, effectively putting the “brakes” on muscle development to prevent excessive growth. ACE 031 works by binding to these proteins before they can attach to their natural receptors on muscle cells, thereby neutralizing their inhibitory effects. This allows for rapid hypertrophic growth of skeletal muscle, making it a primary subject of study for muscle-wasting conditions like Duchenne muscular dystrophy and age-related sarcopenia.

Beyond its primary role in muscle biology, ACE 031 is also researched for its potential systemic metabolic benefits. By increasing lean muscle mass, it inherently alters the body’s muscle-to-fat ratio, which can lead to improved glucose metabolism and enhanced bone density. Unlike traditional anabolic agents that target hormonal pathways, ACE 031 operates through a unique non-hormonal mechanism, providing a distinct model for pharmacological research. As a highly purified compound, it offers researchers a powerful tool to explore the limits of physical regeneration and the complex interplay between myokines and overall metabolic health.